$4.04
2.28% today
Nasdaq, Nov 20, 10:00 pm CET
ISIN
US03837C1062
Symbol
APYX

Apyx Medical Corporation Stock price

$3.95
+0.82 26.20% 1M
+2.46 165.10% 6M
+2.37 150.00% YTD
+2.67 208.59% 1Y
+2.53 178.17% 3Y
-3.03 43.41% 5Y
+2.07 110.11% 10Y
+1.02 34.81% 20Y
Nasdaq, Closing price Wed, Nov 19 2025
+0.14 3.67%

Key metrics

Basic
Market capitalization
$151.1m
Enterprise Value
$160.6m
Net debt
$9.5m
Cash
$25.1m
Shares outstanding
37.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.2 | 3.0
EV/Sales
3.4 | 3.1
EV/FCF
negative
P/B
25.8
Financial Health
Equity Ratio
21.9%
Return on Equity
-165.1%
ROCE
-20.5%
ROIC
-34.8%
Debt/Equity
5.9
Financials (TTM | estimate)
Revenue
$47.9m | $51.0m
EBITDA
$-8.9m | $-6.4m
EBIT
$-9.5m | $-9.9m
Net Income
$-14.5m | $-14.2m
Free Cash Flow
$-9.5m
Growth (TTM | estimate)
Revenue
-1.3% | 6.0%
EBITDA
57.4% | 64.9%
EBIT
55.9% | 47.5%
Net Income
48.9% | 39.6%
Free Cash Flow
47.0%
Margin (TTM | estimate)
Gross
62.7%
EBITDA
-18.6% | -12.6%
EBIT
-19.8%
Net
-30.4% | -27.8%
Free Cash Flow
-19.8%
More
EPS
$-0.4
FCF per Share
$-0.3
Short interest
1.0%
Employees
220
Rev per Employee
$220.0k
Show more

Is Apyx Medical Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

Apyx Medical Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Apyx Medical Corporation forecast:

7x Buy
70%
3x Hold
30%

Analyst Opinions

10 Analysts have issued a Apyx Medical Corporation forecast:

Buy
70%
Hold
30%

Financial data from Apyx Medical Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
48 48
1% 1%
100%
- Direct Costs 18 18
7% 7%
37%
30 30
2% 2%
63%
- Selling and Administrative Expenses 36 36
21% 21%
75%
- Research and Development Expense 3.55 3.55
32% 32%
7%
-8.93 -8.93
57% 57%
-19%
- Depreciation and Amortization 0.58 0.58
5% 5%
1%
EBIT (Operating Income) EBIT -9.51 -9.51
56% 56%
-20%
Net Profit -15 -15
49% 49%
-30%

In millions USD.

Don't miss a Thing! We will send you all news about Apyx Medical Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Apyx Medical Corporation Stock News

Neutral
GlobeNewsWire
2 days ago
CLEARWATER, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced the pricing of its previously announced underwritten public offering of 2,762,431 shares of its common stock at a public offering price of $3.62 ...
Neutral
GlobeNewsWire
3 days ago
CLEARWATER Fla., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”) the leader in surgical aesthetics marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced that it is commencing an underwritten public offering of shares of its common stock (or common stock equivalents). The offering is subject to mark...
Neutral
Seeking Alpha
14 days ago
Apyx Medical Corporation ( APYX ) Q3 2025 Earnings Call November 6, 2025 8:00 AM EST Company Participants Charles Goodwin - President, CEO & Director Matthew Hill - CFO, Treasurer & Secretary Conference Call Participants Jeremy Feffer - Lifesci Advisors, LLC David Turkaly - Citizens JMP Securities, LLC, Research Division Sam Eiber - BTIG, LLC, Research Division Alex Fuhrman - Lucid Capital Mark...
More Apyx Medical Corporation News

Company Profile

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Head office United States
CEO Charles Goodwin
Employees 220
Founded 1978
Website apyxmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today